Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if using the combination of standard chemotherapy
(gemcitabine and cisplatin) plus this new targeted pill (sunitinib) can help shrink your
tumor before you undergo surgery for your bladder cancer.